What is Surterra?
Founded in 2014 and headquartered in Atlanta, Georgia, Surterra Wellness operates as a sophisticated, vertically integrated enterprise within the cannabis industry. The company specializes in the development and distribution of a wide array of health and wellness products, including vaporizer pens, tinctures, oral sprays, topical creams, and transdermal patches. By controlling the supply chain from cultivation to retail, Surterra ensures high-quality standards across its active markets in Florida, Texas, Nevada, and Massachusetts. The firm's market position is defined by its commitment to providing natural medical relief, catering to a growing demographic of consumers seeking alternative wellness solutions through scientifically backed delivery methods.
How much funding has Surterra raised?
Surterra has raised a total of $215.3M across 6 funding rounds:
Multiple Rounds
$40.3M
Series C
$65M
Series D
$100M
Debt
$10M
Private Equity (2016): $15M, investors not publicly disclosed
Series B (2016): $10.3M, investors not publicly disclosed
Series A (2016): $15M, investors not publicly disclosed
Series C (2018): $65M featuring Wrigley
Series D (2019): $100M, investors not publicly disclosed
Debt (2022): $10M with participation from Sunstream
Key Investors in Surterra
Sunstream
Sunstream is a leader in hydraulic marine engineering and lift systems, founded by an aerospace engineer with a focus on advanced mechanical design and innovation.
Wrigley
An institutional backer participating in the company's Series C round, contributing to the firm's long-term capital structure.
Undisclosed Investor
An undisclosed investor participating in the funding round, providing essential liquidity to support the company's strategic growth objectives.
What's next for Surterra?
With the recent infusion of capital, Surterra is well-positioned to accelerate its strategic initiatives, focusing on operational efficiency and market expansion. The company's trajectory suggests a shift toward optimizing its existing footprint while potentially exploring new product innovations that align with evolving consumer preferences in the wellness sector. As the regulatory landscape for cannabis continues to mature, Surterra's ability to leverage its vertical integration will be critical in maintaining its competitive edge. Future growth will likely hinge on the firm's capacity to scale its distribution networks and enhance its brand equity, ensuring that it remains at the forefront of the medical cannabis industry's evolution.
See full Surterra company page
